Identification of micrornas as potential prognostic markers in ependymoma

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Costa, Fabricio F ^a   Bischof, Jared M ^a   Vanin, Elio F ^a   Lulla, Rishi R ^a,b   Wang, Min ^a   Sredni, Simone T ^a   Rajaram, Veena ^b   de Fátima Bonaldo, Maria ^a   Wang, Deli ^b   Goldman, Stewart ^b   Tomita, Tadanori ^b   Soares, Marcelo B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 135A; MICRORNA 17 5P; MICRORNA 367; MICRORNA 383; MICRORNA 485 5P; MICRORNA 596; UNCLASSIFIED DRUG; TUMOR MARKER;

ADOLESCENT; ARTICLE; BRAIN TISSUE; CHILD; CHROMOSOME 14Q; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EPENDYMA CELL; EPENDYMOMA; FEMALE; FROZEN SECTION; GENE CLUSTER; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; MALE; MICRODISSECTION; OVERALL SURVIVAL; PRESCHOOL CHILD; PROGNOSIS; RELAPSE; SCHOOL CHILD; TISSUE SECTION; TUMOR LOCALIZATION; BIOLOGY; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; SURVIVAL;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; EPENDYMOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; MICRORNAS; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80055029189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025114     Document Type: Article

References (39)

1. Robbins, Cotran, (2005) The Central Nervous System. Pathologic Basis of Disease. 7th Edition Philadelphia Elsevier Saunders.
2. Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, et al. (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. Mod Pathol 21 (2): 165-177.
3. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136 (2): 215-233.
4. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
5. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2): 647-658.
6. He XY, Chen JX, Zhang Z, Li CL, Peng QL, et al. (2009) The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol 136 (7): 1023-1028.
7. Mayr C, Hemann MT, Bartel DP, (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (5818): 1576-1579.
8. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447 (7148): 1130-1134.
9. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, et al. (2008) MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 26 (4): 462-469.
10. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (7163): 682-688.
11. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (7175): 147-152.
12. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33 (20): e179.
13. Raymond CK, Roberts BS, Garrett-Engele P, Lim LP, Johnson JM, (2005) Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA 11 pp. 1737-1744.
14. Xie H, Wang M, Bonaldo Mde F, Rajaram V, Stellpflug W, et al. (2010) Epigenomic analysis of Alu repeats in human ependymomas. Proc Natl Acad Sci U S A 107 (15): 6952-6957.
15. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, et al. (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8 (4): 323-335.
16. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, et al. (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466 (7306): 632-636.
17. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, et al. (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12 (7 Pt 1): 2070-2079.
18. Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, et al. (2008) Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182 (1): 18-26.
19. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, et al. (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24 (33): 5223-5233.
20. Tabori U, Wong V, Ma J, Shago M, Alon N, et al. (2008) Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. Br J Cancer 99 (7): 1129-1135.
21. Massimino M, Buttarelli FR, Antonelli M, Gandola L, Modena P, et al. (2009) Intracranial ependymoma: factors affecting outcome. Future Oncol 5 (2): 207-216.
22. Wurdinger T, Costa FF, (2007) Molecular therapy in the microRNA era. Pharmacogenomics J 7 (5): 297-304.
23. Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, et al. (2008) Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 5 pp. 415-423.
24. Jennings MT, Kaariainen IT, Gold L, Maciunas RJ, Commers PA, et al. (1994) TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis. Hum Pathol 5 pp. 464-475.
25. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, et al. (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5 (5): 504-514.
26. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E, et al. (2009) MicroRNA-10b is over-expressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125 (6): 1407-1413.
27. Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, et al. (2010) Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer 56 (2): 211-216.
28. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (14): 6029-6033.
29. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, et al. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67 (19): 8994-9000.
30. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, et al. (2008) Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 2 pp. 237-242.
31. Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, et al. (2010) Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 220 (1): 71-86.
32. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, et al. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13 (6): 496-450.
33. Yi R, Poy MN, Stoffel M, Fuchs E, (2008) A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452 (7184): 225-229.
34. McKenna DJ, McDade SS, Patel D, McCance DJ, (2010) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84 (20): 10644-10652.
35. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, et al. (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126 (1): 73-80.
36. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, et al. (2010) Aberrant Expression of miR-203 and Its Clinical Significance in Gastric and Colorectal Cancers. J Gastrointest Surg [Epub ahead of print].
37. Peter ME, (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 15;8 (6): 843-852.
38. Williams SV, Platt FM, Hurst CD, Aveyard JS, Taylor CF, et al. (2010) High-resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma. Genes Chromosomes Cancer 49 (7): 642-659.
39. Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, et al. (2009) Target identification of microRNAs expressed highly in human embryonic stem cells. J Cell Biochem 106 (6): 1020-1030.